Research output: Contribution to journal › Review article › peer-review
Fingerprint
Dive into the research topics of 'Momelotinib (JAK1/JAK2/ACVR1 inhibitor): mechanism of action, clinical trial reports, and therapeutic prospects beyond myelofibrosis'. Together they form a unique fingerprint.